News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.



British study in children shows racial disparities in COVID-19 testing, outcomes

By Linda Carroll (Reuters Health) - Minority children in England were less likely to be tested for COVID-19, but more likely to be positive when tested, than white children, researchers there report.

FDA documents show struggle over approval of new Alzheimer's drug from Biogen

By Julie Steenhuysen (Reuters) - The U.S. Food and Drug Administration on Tuesday released a sweeping series of memos revealing a clear struggle within the agency ahead of its controversial decision

Levothyroxine remains common in U.S. for mildly increased thyrotropin

By Lisa Rapaport (Reuters Health) - Many U.S. patients taking levothyroxine started treatment when they had subclinical hypothyroidism and only mildly increased thyrotropin levels, a recent study

Alcohol tied to reduced fecundability, particularly at 3+ drinks a week

By Lisa Rapaport (Reuters Health) - Women who consume three or more drinks a week during the luteal phase of their menstrual cycle or more than six weekly drinks during the ovulatory window may

No benefit to therapeutic oral anticoagulation in COVID-19 hospitalizations

By Marilynn Larkin NEW YORK (Reuters Health) - In patients hospitalized with COVID-19 and elevated D-dimer concentrations, therapeutic dosing of oral anticoagulants did not improve outcomes compared

'Epsilon' variant not more common in mRNA-vaccinated healthcare workers

By Linda Carroll (Reuters Health) - SARS-CoV-2 breakthrough infections were rare in a cohort of fully vaccinated California healthcare workers and the Epsilon variant of concern was no more likely

Biomarker may predict neurological damage in COVID-19

By Marilynn Larkin NEW YORK (Reuters Health) - Concentrations of neurofilament light chain (NFL), a marker of neuroaxonal injury, predicted the extent of neuronal damage in a cohort of patients

Toxic PFAS taint lipsticks, mascaras and other makeup

By Ronnie Cohen (Reuters Health) - More than half the cosmetics sold in the United States and Canada have high levels of PFAS, chemicals associated with increased cancer risks, decreased vaccine

Delta COVID-19 variant greatest threat to U.S. pandemic response -Fauci

By Carl O'Donnell (Reuters) - The Delta variant of the novel coronavirus that was first found in India is the greatest threat to the United States' effort to eradicate COVID-19 in its borders, said

India says new COVID variant is a concern

By Uday Sampath Kumar and Bhargav Acharya BENGALURU (Reuters) - India on Tuesday declared a new coronavirus variant to be of concern, and said nearly two dozen cases had been detected in three states.

Prisoners going through menopause get "double punishment"

By Ronnie Cohen (Reuters Health) - For a growing population of aging incarcerated women, the transition to menopause can be especially fraught yet largely overlooked by prison healthcare systems, a

Migraine not just a neurological problem for pregnant women

By Megan Brooks NEW YORK (Reuters Health) - Women who suffer from migraines have an increased risk of experiencing pregnancy complications, new research from Israel indicates. For pregnant women, "

More support for antibiotics alone in kids with uncomplicated appendicitis

By Megan Brooks NEW YORK (Reuters Health) - For children with uncomplicated appendicitis, the success rate of initial treatment with antibiotics is unlikely to differ by age and other factors,

Target systolic BP to less than 120 mm Hg in kidney patients not on dialysis: guidelines

By Reuters Staff NEW YORK (Reuters Health) - Updated advice on managing blood pressure in patients with chronic kidney disease (CKD) not receiving dialysis recommends targeting systolic BP to less

Turkish COVID-19 vaccine starts Phase III trials

By Reuters Staff ISTANBUL (Reuters) - Turkey on Tuesday kicked off Phase III trials for its COVID-19 vaccine, named "Turkovac" by President Tayyip Erdogan who said the shot should be available for use

Volunteers spread word on vaccines to India's poor after deadly COVID-19 surge

By Uday Sampath Kumar BENGALURU (Reuters) - Volunteer groups are spreading the word about getting COVID-19 shots to India's poor and elderly, and ferrying some to vaccination centres in rickshaws and

Cuba says Abdala vaccine 92.28% effective against coronavirus

By Reuters Staff HAVANA (Reuters) - Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials. The announcement came just days

School COVID-19 cases spur Israeli parents to vaccinate kids

By Rami Amichay TEL AVIV (Reuters) - A weak link in Israel's world-beating COVID-19 vaccination rollout until now, adolescents have found themselves on the frontline of the campaign with fears of the

Moderna vaccine transmission prevention study to include young adults

By Mrinalika Roy (Reuters) - U.S. scientists are expanding a government-funded study that aims to directly answer the question of whether Moderna Inc's COVID-19 vaccine curbs the spread of SARS-CoV-2.

Coffee tied to lower risk of chronic liver disease, liver disease death

By Lisa Rapaport (Reuters Health) - People who drink any type of coffee, whether or not it contains caffeine, are less likely to develop or die from chronic liver disease than counterparts who drink

Convalescent plasma may boost COVID-19 survival in blood cancer patients

By Marilynn Larkin NEW YORK (Reuters Health) - Convalescent plasma conferred a survival benefit when given to COVID-19-positive patients with hematologic cancer in a multicenter cohort study. "This is

Sotagliflozin reduces disease burden in diabetes with worsening heart failure

By Reuters Staff NEW YORK (Reuters Health) - For patients with type-2 diabetes and worsening heart failure, treatment with sotagliflozin, a sodium-glucose cotransporter-1 (SGLT1) and SGLT2 inhibitor,

WHO setting up hub to make COVID-19 vaccines in South Africa

By Emma Farge and Matthias Blamont GENEVA (Reuters) - The WHO is setting up a hub in South Africa to give companies from poor and middle-income countries the know-how and licenses to produce COVID-19

Advanced colorectal neoplasia risk seen before age 50

By Lisa Rapaport (Reuters Health) - Average-risk individuals who undergo screening colonoscopy at ages 45 to 49 have a risk of early-age onset colorectal neoplasia that is similar to people in the 50-

SARS-CoV-2 may exploit injured kidney cells to cause infection, damage

By Marilynn Larkin NEW YORK (Reuters Health) - SARS-CoV-2 does not seem to injure the kidney directly, but may trigger acute injury or tubular damage in already injured cells, a preclinical study

CDC says U.S. young adults less likely to take COVID-19 vaccine

By Reuters Staff (Reuters) - Younger adults are seeking out COVID-19 vaccines at a slower rate than older adults, and if that pace of vaccination continues through August, vaccine coverage among

UPDATE 1-Israel urges adolescents to get vaccinated, citing Delta variant

(Adds official recommendation and other details) By Reuters Staff JERUSALEM (Reuters) - Israel on Monday recommended that all 12-15 year-olds be vaccinated against COVID-19, citing new outbreaks

Dual-antibody drugs effective against COVID-19 variants in animal study

By Dania Nadeem (Reuters) - COVID-19 therapies made from a cocktail of two types of antibodies were effective against a wide range of variants of the coronavirus in a mice and hamster study,

White House lays out plan to share remaining 55 mln U.S. COVID-19 shots globally

By Reuters Staff (Reuters) - The White House on Monday laid out a plan to share 55 million U.S. COVID-19 vaccine doses globally, with roughly 75 percent of the doses allocated to Latin America and the

China's Dongguan is latest southern city to be hit by COVID-19

By Ryan Woo, Muyu Xu and Roxanne Liu BEIJING (Reuters) - The manufacturing hub of Dongguan in China's most populous province Guangdong launched mass coronavirus testing on Monday and cordoned off

Israel urges adolescents to get vaccinated, citing Delta variant

By Reuters Staff JERUSALEM (Reuters) - An Israeli health official on Monday urged more 12- to 15-year-olds to be vaccinated against COVID-19, citing new outbreaks that he attributed to the more

More evidence for a 'Mozart effect' on the epileptic brain

By Reuters Staff NEW YORK (Reuters Health) - Listening to Mozart's piano music improves epilepsy by reducing epileptiform discharges, according to new research. There was a "clear decrease in

Mechanistic link between eating red meat and colon cancer revealed

By Megan Brooks NEW YORK (Reuters Health) - Red meat consumption has been consistently linked to an increased risk for colorectal cancer and a new study provides a mechanistic reason. "Our study

Pralsetinib promising new agent for RET fusion-protein-positive lung cancer

By Reuters Staff NEW YORK (Reuters Health) - Oral pralsetinib elicits strong antitumor activity in patients with advanced or metastatic non-small-cell lung cancer (NSCLC) that tests positive for

Study confirms GSK-Vir antibody drug reduces hospitalization, death in COVID-19 patients

By Reuters Staff (Reuters) - GlaxoSmithKline Plc and Vir Biotechnology said on Monday final results from a late-stage study of their monoclonal antibody confirmed it significantly reduced

Gilead's remdesivir reduces COVID-19 mortality risk- data

By Reuters Staff (Reuters) - Gilead Sciences Inc said an analysis showed its antiviral remdesivir reduced mortality rates in hospitalized patients with COVID-19 and increased the likelihood of being

U.S. employers wrestle with COVID vaccine requirements in regulatory 'hairball'

By Tom Hals (Reuters) - America's largest garlic farm needs 1,000 workers to harvest its annual crop, but faces an unexpected hurdle in this year's recruitment drive: it now must document and track

Putin says COVID-19 trend is getting worse, Kremlin pushes revaccination

By Reuters Staff MOSCOW (Reuters) - President Vladimir Putin warned on Monday that the coronavirus situation in some Russian regions was getting worse as authorities began promoting the idea of

Brazil passes half a million COVID-19 deaths, experts warn of worse ahead

By Eduardo Simões SAO PAULO (Reuters) - Brazil's death toll from COVID-19 surpassed 500,000 on Saturday as experts warn that the world's second-deadliest outbreak may worsen due to delayed

Cuba encouraged by early efficacy results of homegrown COVID-19 vaccine

By Nelson Acosta HAVANA (Reuters) - Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday,

BioNTech shots have stronger antibody response than Sinovac, Hong Kong study shows - SCMP

By Reuters Staff (Reuters) - People who are vaccinated against COVID-19 with Pfizer/BioNTech's vaccine were found to have "substantially higher" levels of antibodies than those who received Sinovac's

Are Medicare beneficiaries with knee osteoarthritis receiving enough conservative care?

By Marilynn Larkin NEW YORK (Reuters Health) - Non-surgical care for knee osteoarthritis is uncommon among older adults, especially in regions of the U.S. where total knee arthroplasty (TKA) rates are

Rituximab seems safe and effective for systemic sclerosis

By Marilynn Larkin NEW YORK (Reuters Health) - Rituximab seemed to be a safe and effective treatment for systemic sclerosis in a placebo-controlled validation trial in Japan. "A number of studies have

COVID-19 survivors may have loss of brain tissue

By Reuters Staff (Reuters) - Even mild cases of COVID-19 may lead to loss of brain tissue, according to findings from a long-term study involving 782 volunteers. As part of the ongoing UK Biobank

Most results from e-cigarette trials improperly reported, or not reported at all

By Linda Carroll (Reuters Health) - Of five clinical trials listed on ClinicalTrials.gov and sponsored by JUUL Labs, only one resulted in a published paper and none had results posted on the

Disproportionate share of international medical graduates died from COVID-19 in U.S.

By Lisa Rapaport (Reuters Health) - In many states, a larger share of physicians trained outside the U.S. than their representation in the workforce died due to COVID-19, a recent study suggests.

Financial toxicity of having CVD worse than with cancer in U.S.

By Lisa Rapaport (Reuters Health) - American adults with atherosclerotic cardiovascular disease may experience greater financial toxicity than those with cancer, a U.S. study suggests. Researchers

One in six pregnant women delivering in a U.S. hospital may see a big bill, even with insurance

By Linda Carroll (Reuters Health) - For as many as one in six families who have private health insurance, there can be sticker shock when they see their portion of the bill for a hospital delivery, a

German lab, J&J still hashing out details of COVID-19 vaccine clot collaboration

By John Miller ZURICH (Reuters) - A scientist investigating rare blood clots possibly linked to AstraZeneca's and Johnson & Johnson's COVID-19 vaccines has yet to start a planned collaboration with

California launches digital COVID-19 vaccine pass but won't require it

By Paresh Dave OAKLAND, Calif. (Reuters) - California officials on Friday unveiled a website to access or download a digital copy of COVID-19 immunization records, though they stressed the state would

Delta COVID variant becoming globally dominant, WHO official says

By Reuters Staff GENEVA (Reuters) - The Delta variant of COVID-19, first identified in India, is becoming the globally dominant variant of the disease, the World Health Organization's chief scientist

ANALYSIS-Rival treatments may help justify FDA gamble with Biogen Alzheimer's drug

By Deena Beasley and Julie Steenhuysen (Reuters) - Data from clinical trials of three experimental Alzheimer's disease drugs expected to start emerging next year could help shed light on whether U.S.

COVID surges, but Russians resist coaxing and compulsion to get vaccinated

By Polina Nikolskaya and Anton Zverev MOSCOW (Reuters) - Seemingly lost for an explanation of why vaccine uptake is so low in Russia when coronavirus infections are soaring and vaccines are readily

UPDATE 1-Kremlin blames vaccine hesitancy as Delta variant drives Moscow surge

(Adds parliamentary voting extension in paragraph 10, restores date of June 2 in paragraph 9) By Reuters Staff MOSCOW (Reuters) - The Kremlin on Friday blamed a surge in COVID-19 cases on reluctance

Chemotherapy during pregnancy needn't harm the fetus

By David Douglas NEW YORK (Reuters Health) - Although chemotherapy within the first trimester of pregnancy is associated with an increased risk of major congenital malformations, treatment delay

CORRECTED-Kremlin blames vaccine hesitancy as Delta variant drives Moscow surge

(In paragraph 9, corrects date of latest vaccination tally to June 12, not June 2; updates headline) By Reuters Staff MOSCOW (Reuters) - The Kremlin on Friday blamed a surge in COVID-19 cases on

EXCLUSIVE-Google searches for new measure of skin tones to curb bias in products

By Paresh Dave (Reuters) - Alphabet Inc's Google told Reuters this week it is developing an alternative to the industry standard method for classifying skin tones, which a growing chorus of technology

In early lung cancer, immunotherapy plus targeted radiation may up response rate

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Patients with non-small-cell lung cancer (NSCLC) may respond more quickly to neoadjuvant durvalumab combined with stereotactic body radiotherapy

AI-enhanced ECG can help rapidly rule out COVID-19

By Reuters Staff NEW YORK (Reuters Health) - Artificial intelligence (AI)-enhanced electrocardiograms (ECGs) can detect subtle, subclinical electrical changes in the heart associated with SARS-CoV-2

Strict rest after sports concussion slows recovery, progressive moderate exercise helpful: experts

By Megan Brooks NEW YORK (Reuters Health) - Strict rest after a sports-related concussion slows recovery and may prolong symptoms, whereas progressive moderate aerobic exercise within the first week

Thailand scraps plan for 16-week dose gap on AstraZeneca vaccine

By Reuters Staff BANGKOK (Reuters) - Thailand has abandoned its plan for a 16-week gap between doses of the AstraZeneca coronavirus vaccine and will opt for a shorter interval of 10 to 12 weeks

S.Korea to mix-and-match COVID-19 vaccine doses for 760,000 people

By Sangmi Cha SEOUL (Reuters) - Some 760,000 South Koreans who have received a first dose of AstraZeneca Plc's COVID-19 vaccine will be offered Pfizer Inc's vaccine as a second shot due to shipment

Delta variant of coronavirus seen dominant in Germany by autumn

By Joseph Nasr BERLIN (Reuters) - The more infectious Delta coronavirus variant will become dominant in Germany by the autumn at the latest, the country's top public health official said on Friday,

Kremlin blames 'nihilism' as Moscow sees record COVID-19 infections

By Reuters Staff MOSCOW (Reuters) - The Kremlin on Friday blamed a surge in COVID-19 cases on "nihilism" and reluctance to have vaccinations after a record 9,056 new infections in Moscow, mostly with

India should brace for third COVID-19 wave by Oct, say health experts

By Shrutee Sarkar BENGALURU (Reuters) - A third wave of coronavirus infections is likely to hit India by October, and although it will be better controlled than the latest outbreak the pandemic will

'Ice' flavored e-cigarettes tied to nicotine dependence among young adults

By Lisa Rapaport (Reuters Health) - Young adults who use e-cigarettes with fruity "cooling" flavors like blueberry-ice and melon-ice may be at higher risk of nicotine dependence than vapers who favor

High-priority patients often don't make it to the kidney-transplant wait list

By Reuters Staff NEW YORK (Reuters Health) - Kidney transplantation is often the best option for people with end-stage kidney disease (ESKD), but many "high priority" patients are not placed on the

Polymyositis-dermatomyositis tied to arrhythmias in young, middle-aged adults

By Lisa Rapaport (Reuters Health) - Young and middle-aged adults with polymyositis-dermatomyositis are more likely to have arrhythmias in general, and supraventricular arrhythmias in particular, than

FACTBOX-Five Chinese scientists face U.S. visa fraud charges

By Jane Lanhee Lee (Reuters) - The United States Department of Justice in late 2018 launched the "China Initiative" to stem the theft of trade secrets by Chinese entities and keep technology developed

FOCUS-Chinese scientists ensnared in U.S. visa fraud legal battle

By Jane Lanhee Lee SAN FRANCISCO (Reuters) - For Chinese brain researcher Song Chen, a visiting scholar at Stanford University when she was arrested last July on a visa fraud charge, a court hearing

Drop in Havana COVID-19 cases boosts hopes Cuban vaccines working

By Sarah Marsh HAVANA (Reuters) - Coronavirus infections have halved in Havana since authorities started administering Cuba's experimental vaccines en masse in the capital a month ago, official data

Moscow facing new aggressive coronavirus variant, mayor says

By Tom Balmforth and Andrey Ostroukh MOSCOW (Reuters) - Moscow is facing a new coronavirus variant that is more aggressive and infectious, and the situation in the city is rapidly deteriorating, its

CureVac may let contractors make rival vaccines if own shot fails - CEO

By Tilman Blasshofer and Ludwig Burger FRANKFURT (Reuters) - German biotech firm CureVac could allow its network of manufacturing partners to be repurposed to make vaccines developed by other

No benefit to routine use of platinum agents after neoadjuvant chemo in triple-negative breast cancer

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with triple-negative breast cancer (TNBC) and residual invasive disease (RD), there is no benefit and more toxicity when platinum agents are

Cancer patients at high risk of death from COVID-19 identified

By Marilynn Larkin NEW YORK (Reuters Health) - Using real-world data, researchers identified characteristics of cancer patients at highest risk of mortality from COVID-19. "We set out to take

Former Swiss 'Magic Mountain' TB clinics treat COVID to stay relevant

By John Miller WALD/DAVOS, Switzerland (Reuters) - Swiss mountain sanatoriums whose fresh-air and sunlight cures once drew tuberculosis patients from across Europe are reinventing themselves for a new

UPDATE 1-European regulator EMA says it won't set 50% efficacy threshold for COVID shots

(Adds details, quotes) By Reuters Staff (Reuters) - The European Medicines Agency (EMA) said on Thursday it would not impose a 50% efficacy threshold for COVID-19 vaccines, adding full trial data was

OCT corneal epithelial mapping may help doctors better diagnose dry eye

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Optical coherence tomography (OCT) corneal epithelial mapping can help doctors better screen for and stage dry-eye disease (DED), new research

Pfizer's rheumatoid arthritis drug shows benefit in COVID-19 pneumonia

By Reuters Staff (Reuters) - Pfizer Inc said on Wednesday its oral rheumatoid arthritis drug Xeljanz reduced death or respiratory failure in hospitalized COVID-19 patients with pneumonia in Brazil,

COVID-19 cases surge in Africa, less than 0.8% of fully vaccinated, say officials

By Reuters Staff NAIROBI (Reuters) - COVID-19 cases rose by over 20% week-on-week in nearly two dozen African countries and progress on vaccinating Africans is proceeding slowly, with just 0.79% of

China disease expert says COVID-19 origins probe should shift to U.S.- Global Times

By Reuters Staff SHANGHAI (Reuters) - A senior Chinese epidemiologist said the United States should be the priority in the next phase of investigations into the origin of COVID-19 after a study showed

EMA says setting 50% efficacy threshold for COVID-19 vaccines is difficult

By Reuters Staff (Reuters) - The European Medicines Agency (EMA) said on Thursday it was not willing to impose a 50% efficacy threshold for COVID-19 vaccines, adding full trial data was necessary for

No benefit to post-op heparin bridging in patients who stop warfarin for a procedure

By Reuters Staff NEW YORK (Reuters Health) - There does not appear to be a benefit to postoperative heparin bridging in patients with atrial fibrillation or a mechanical heart valve who temporarily

Lipid management lacking in patients with peripheral-artery disease

By David Douglas NEW YORK (Reuters Health) - Lipid-lowering therapies aimed at reducing low-density-lipoprotein cholesterol (LDL-C) are underused, according to a study of more than a quarter of a

ECG biomarker identifies AFib patients most likely to benefit from electrical stimulation

By Brandon May NEW YORK (Reuters Health) - P-wave alternans (PWA) may act as a biomarker for identifying patients with atrial fibrillation (AF) who are most likely to benefit from chronic low-level

COVID-19 vaccine safe and effective in cancer patients on active treatment

By Reuters Staff NEW YORK (Reuters Health) - A new study confirms the safety and effectiveness of COVID-19 vaccines in adults with cancer receiving active treatment, a potentially vulnerable

U.S. Supreme Court rejects Republican challenge to Obamacare law

By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Thursday rejected a Republican bid that had been backed by former President Donald Trump's administration to invalidate the

Hundreds of vaccinated Indonesian health workers get COVID-19, dozens in hospital

By Kate Lamb, Agustinus Beo Da Costa and Stanley Widianto JAKARTA (Reuters) - More than 350 doctors and medical workers have caught COVID-19 in Indonesia despite being vaccinated with Sinovac and

Delta variant fuelled 50% rise in English COVID prevalence -study

By Reuters Staff LONDON (Reuters) - The rapid spread of the Delta coronavirus variant has driven a 50% rise in infections in England since May, a large prevalence study led by Imperial College London

Low dosage may be behind low efficacy of CureVac vaccine -study leader

By Caroline Copley BERLIN (Reuters) - The low dosage might be a key reason why CureVac's COVID-19 vaccine reported disappointing efficacy in a pivotal late-stage trial, the scientist leading the study

Privacy may be at risk with medical and health apps

By Linda Carroll (Reuters Health) - Personal data may be at risk with many health and medical apps, a new study suggests. An in-depth analysis of more than 20,000 health related apps available through

Regeneron COVID-19 drug helps hardly-sick and very-sick patients

By Reuters Staff (Reuters) - An antibody cocktail from Regeneron Pharmaceuticals Inc and Roche showed benefits for a wide range of COVID-19 patients, from those without symptoms to hospitalized

Some lymph node cancers limit COVID-19 vaccine responses

By Reuters Staff (Reuters) - Some patients with lymph node cancers will have good antibody responses to COVID-19 vaccines, but others will need further protection, according to new data. The UK

Gut microbiome tied to non-social fear response in infants

By Marilynn Larkin NEW YORK (Reuters Health) - The composition of the gut microbiome is associated with how infants experience non-social fear - e.g., fear in response to someone wearing a mask

UPDATE 1-CureVac's COVID-19 vaccine misses efficacy goal in pivotal trial

(Adds trial details) By Reuters Staff (Reuters) - German biotech group CureVac said in a statement (https://bit.ly/3wtwlmS) on Wednesday its mRNA-based COVID-19 vaccine was shown to be 47% effective

CureVac's COVID-19 vaccine misses efficacy goal in mass trial

By Reuters Staff (Reuters) - German biotech group CureVac said in a statement (https://bit.ly/3wtwlmS) on Wednesday its mRNA-based COVID-19 vaccine was shown to be 47% effective against disease in a

Biomarkers pinpoint resistant prostate cancer that may benefit from addition of apalutamide

By Marilynn Larkin NEW YORK (Reuters Health) - Biomarkers can be used to identify patients with prostate cancer refractory to first-line androgen deprivation therapy (ADT) who might benefit from the

IVIG, glucocorticoids or both produce similar outcomes against MIS-C

By Gene Emery (Reuters Health) - A large international study has concluded that children who develop multisystem inflammatory syndrome (MIS-C) after infection with SARS-CoV-2 may derive comparable

Presumed sudden cardiac death among HIV-infected often not due to coronary-artery disease

By Gene Emery NEW YORK (Reuters Health) - People with HIV have a rate of sudden cardiac death that is more than double that in the non-infected population, according to a new study of cases in San

Therapeutic hypothermia offers no survival benefit for comatose patients after cardiac arrest

By Gene Emery NEW YORK (Reuters Health) - A large multinational study may cool enthusiasm for using hypothermia to treat comatose patients recovering from an out-of-hospital cardiac arrest. The test

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.


© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information